Clinical Trials Directory

Trials / Unknown

UnknownNCT06224166

Analysis of HPV and Biomarkers Present in the Biological Fluids of Patients Suffering From Head and Neck Cancer as a Non-invasive Strategy for Detecting Recurrence

Status
Unknown
Phase
Study type
Observational
Enrollment
283 (estimated)
Sponsor
Regina Elena Cancer Institute · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Multicenter, non-interventional, retrospective/prospective biological study on patients affected by head and neck tumors, for which the collection and use of tissue samples, blood and saliva for the detection of HPV-DNA/RNA and miRNA.

Detailed description

For each patient they will come collected tissue, blood and saliva samples. In particular, as regards tissue collection, tumor and neighboring tissues will be used healthy specimens taken during surgical removal, according to clinical practice. The fresh tissues thus collected will be stored in RNA-later before freezing at - 80°C. Furthermore, blood and saliva samples will be taken at different times, in particular: i) the day before surgery; ii) the day after surgery (only for blood); iii) at the time of patient discharge (approximately 15 days after surgery); iii) during the check-up visit scheduled to monitor the patient's follow-up (FU): every 3 months for the first 2 years and every 6 months for the following 3 years. The samples will then be used to carry out nucleic acid extraction, the DNA will instead be used to detect the presence of HPV.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCollection and use of tissue samples, blood and salivaFor tissue collection, tumor and surrounding tissues will be used healthy specimens taken during surgical removal, according to clinical practice. Blood and saliva sampling will be carried out at different times: i) the day before surgery; ii) the day after surgery (only for blood); iii) at the time of patient discharge (approximately 15 days after surgery); iii) during the check-up visit scheduled to monitor the follow-up (FU)

Timeline

Start date
2023-01-17
Primary completion
2025-01-17
Completion
2025-01-17
First posted
2024-01-25
Last updated
2024-01-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06224166. Inclusion in this directory is not an endorsement.